Vincristine - An effective treatment of corticoid-resistant life-threatening infantile hemangiomas

Acta Oncologica

Volumn 41, Issue 2, 2002, Pages 197-199

  Perez, Jaime ^a   Pardo, José ^a   Gomez, Cristina ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; VINCRISTINE;

ARTICLE; CASE REPORT; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMAN; INFANT; KASABACH MERRITT SYNDROME; MALE; NEWBORN; PRIORITY JOURNAL; STEROID THERAPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE; FEMALE; HEMANGIOENDOTHELIOMA; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; SKIN NEOPLASMS; SYNDROME; VINCRISTINE;

EID: 0036265364     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418602753669607     Document Type: Article

References (15)

1. Interferon alpha-2a therapy for life-threatening hemangiomas of infancy
2. The role of tranexamic acid in the treatment of giant hemangiomas in newborns
3. Facial vascular malformations in children. Conventional and digital diagnostic and therapeutic angiography
4. Classification and clinical and histopathological features of hemangiomas and other vascular malformations
5. Solid tumours of childhood
6. Kasabach-Merritt syndrome
7. Concurrent cutaneous and hepatic hemangiomata in infancy: Report of a case and a review of the literature
8. Treatment of hemangiomas of infants with high doses of prednisone
9. Outcome of radiation therapy for patients with Kasabach-Merritt syndrome
10. Laser treatment of port-wine status and hemangiomas
11. Treatment of massive or life-threatening hemangiomas with recombinant alpha (2a)-interferon
12. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
13. Anticancer agents currently in phase I and II trials